Santa Cruz, CA, United States of America

Miten Jain

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Miten Jain: Innovator in Ribonucleic Acid Analysis

Introduction

Miten Jain is a prominent inventor based in Santa Cruz, CA (US). He has made significant contributions to the field of molecular biology, particularly in the analysis of ribonucleic acids (RNAs). With a total of 4 patents, Jain's work has advanced the understanding and manipulation of nucleic acids.

Latest Patents

Jain's latest patents include innovative methods for analyzing capped ribonucleic acids. These methods involve translocating an adapted RNA through a nanopore device, allowing for the monitoring of ionic current during the process. This technique enables the identification of ionic current features that are characteristic of the 5' cap of the RNA. Additionally, Jain has developed methods for producing size-selected nucleic acid libraries. These methods utilize nucleic acid binding reagents to separate nucleic acids based on their length, resulting in a library that is tailored for specific applications.

Career Highlights

Miten Jain is affiliated with the University of California, where he conducts his research and development. His work has garnered attention for its potential applications in biotechnology and genetic research. Jain's innovative approaches have positioned him as a key figure in the field of nucleic acid analysis.

Collaborations

Jain collaborates with notable colleagues, including Mark Albert Akeson and Hugh Edward Olsen. These partnerships enhance the scope and impact of his research, fostering advancements in molecular biology.

Conclusion

Miten Jain's contributions to the field of RNA analysis and nucleic acid library production highlight his role as an influential inventor. His innovative methods and collaborations continue to push the boundaries of scientific research and application.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…